KIYAN MEDICAL Organization Chart
- KIYAN PHARMA Co., Ltd.
- KIYAN MEDICAL Co., Ltd.
- Biozipcode, Inc.
- Shiga University of Medical Science, Department of Regenerative Medicine Development (Partnership)
- KIYAN PHARMA Co., Ltd.
- KIYAN MEDICAL Co., Ltd.
- Biozipcode, Inc.
- Shiga University of Medical Science, Department of Regenerative Medicine Development (Partnership)
KIYAN PHARMA Co., Ltd.
Empowering Global Health with 5-ALA Innovations
KIYAN PHARMA Corporation is involved in contract manufacturing and operates across various sectors including health food and cosmetics, animal health, and the agriculture sectors encompassing livestock and aquaculture, all utilizing 5-Aminolevulinic Acid (5-ALA). We contribute to the health of both people and animals. By employing a unique fermentation technology using photosynthetic bacteria, we maintain the world’s only facility capable of producing 5-ALA in large quantities. With innovative products and technologies originating from Japan, we contribute to global health improvement.
KIYAN MEDICAL Co., Ltd.
DNA of a Company Capable of Pharmaceutical Manufacturing and R&D
KIYAN MEDICAL Co., Ltd. was established in October 2023 as a company capable of consistently conducting drug discovery projects. We provide an environment where everything from university research to social implementation, and from R&D to clinical trials, can be undertaken in-house.
KIYAN MEDICAL Co., Ltd.
We provide cutting-edge technologies and services to shape the future of healthcare. From basic research to societal implementation, we offer comprehensive solutions for the development of medical and beauty products, supply of medical devices and testing equipment. Additionally, we contribute to the entire field of life sciences through innovations in food, animal products, and agricultural technologies.
Our goal is to bring innovative ideas to the real world at every phase of research, development, and patent management, contributing to society. Utilizing our technical skills and expertise, we are committed to being a bridge to a better future.
Biozipcode, Inc.
Goodbye. Diabetes.
Aiming for a complete cure rather than symptomatic treatment with “a cure for diabetes” and “technology to deliver drugs to specific cells (cell targeting technology).”
Shiga University of Medical Science, Department of Regenerative Medicine
Innovative regenerative medicine technology development and complete cure for diabetes
In this department, we create a new paradigm for disease treatment by integrating the latest biological knowledge with advanced engineering technology. We focus on repairing and regenerating damaged tissues and organs, aiming to develop customized treatments for individual patients. Through these efforts, we bring new hope to the treatment of previously untreatable diseases and pave the way for the future of the medical field.
About “KIYAN MEDICAL”
As a pharmaceutical “Entity”, we’re committed to contributing to a healthy, sustainable future.
Prioritizing research’s social implementation, we aim to shape medicine’s future and benefit society.
Our essence reflects our philosophy and impact on lives through our products and technologies.
KIYAN MEDICAL consistently bridges research, manufacturing, and treatment, enhancing health care.
Committed to stakeholders’ needs, we adapt to global changes, ensuring resilience and relevance.
Our mission is to enhance lives through impactful health products and services, promoting well-being.
A policy aligned with the “Act on the Protection of Personal Information” governs our handling of personal data.
